Quantcast
FDA Approves Contrave A New Drug To Battle Obesity

FDA Approves Contrave, A New Drug To Battle Obesity

John Hopton for redOrbit.com - Your Universe Online The Food and Drug Administration (FDA) has approved the weight loss pill Contrave, a medication that will be used to treat obese adults in conjunction with a controlled diet and exercise. It...

Latest Organochlorides Stories

2014-09-19 23:08:36

SNBL Clinical Pharmacology Center, Inc. (SNBL CPC), a 96-bed clinical pharmacology research unit specializing in complex early-phase trials, announced today the successful completion of a validation study of the NeuroCart. The study validated the NeuroCart as an effective tool for detection of benzodiazepine-evoked pharmacodynamic CNS effects. Baltimore, MD (PRWEB) September 19, 2014 SNBL Clinical Pharmacology Center, Inc. (SNBL CPC), a 96-bed clinical pharmacology research unit...

2014-09-19 08:25:32

VIENNA, September 19, 2014 /PRNewswire/ -- Australian researchers have discovered that the reductions in heart events and death, from using blood pressure-lowering drugs in patients with type 2 diabetes, persist for many years after treatment has stopped. The global study has found that, six years after stopping intensive treatment with the combination of perindopril and indapamide, patients with type 2 diabetes continued to have a lower risk of serious heart disease...

2014-09-18 08:30:35

MOUNTAIN VIEW, Calif., Sept.18, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today provided an update on the commercial activities related to ADASUVE(®) inhalation powder, pre-dispensed (Staccato(®) loxapine) in the European Union (EU). Grupo Ferrer Internacional, S.A. (Ferrer) is Alexza's commercial partner for ADASUVE in the European Union, Latin America and the CIS countries (the Ferrer Territory). Ferrer has distribution agreements with AOP Orphan Pharmaceuticals...

2014-09-15 23:06:37

Citizens Commission on Human Rights, the nation's leading mental health watchdog, in its latest article, says that Congress should look into possible conflicts of interest on the part of psychiatrists whose antidepressant studies that the Veterans Administration relies upon, as it may provide answers to why suicides linked to antidepressants and sudden deaths from antipsychotics are not being investigated. Los Angeles, California (PRWEB) September 15, 2014 Citizens Commission on Human...

2014-09-12 16:23:36

DUBLIN, Sept. 12, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Diclofenac Industry Report 2014" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 The Global Diclofenac Industry Report 2014 is a professional and in-depth study on the current state of the global diclofenac industry . The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The...

2014-09-11 12:26:49

The Obesity Society Calls FDA Approval of Contrave a Step to Improve Health, Weight of Nation SILVER SPRING, Md., Sept. 11, 2014 /PRNewswire-USNewswire/ -- As the number of Americans affected by severe obesity continues to rise, equipping our nation's doctors with proven and effective tools to treat patients for this disease is increasingly important. Today's Food and Drug Administration (FDA) announcement that Contrave(TM) (combination of naltrexone sustained release [SR]...

2014-09-11 08:27:41

New Medication for Obese Adults, or Overweight Adults with at Least One Weight-Related Comorbid Condition DEERFIELD, Ill., and LA JOLLA, Calif., Sept. 11, 2014 /PRNewswire/ -- Takeda Pharmaceuticals U.S.A., Inc. and Orexigen® Therapeutics, Inc. (Nasdaq: OREX) jointly announced today that the U.S. Food and Drug Administration (FDA) has approved Contrave® (naltrexone HCI and bupropion HCI) extended-release tablets as an adjunct to a reduced-calorie diet and increased physical activity for...

sedative alzheimers link
2014-09-11 05:22:28

Chuck Bednar for redOrbit.com - Your Universe Online Benzodiazepine, a sedative that is widely prescribed to treat people suffering from anxiety and insomnia, have been linked to a 50 percent increase in the risk of Alzheimer's disease, a team of French and Canadian researchers reported Tuesday in the online edition of the journal BMJ. In the study, lead investigator Sophie Billioti de Gage of the University of Bordeaux and her colleagues looked at nearly 2,000 cases of Alzheimer’s...

2014-09-10 23:02:27

ReportsnReports.com adds “2014 Market Research Report on Global Diclofenac Industry” and “2014 Deep Research Report on Global and China DL-Mandelic Acid Industry” report to its store. Dallas, TX (PRWEB) September 10, 2014 2014 Market Research Report on Global Diclofenac Industry is a professional and in-depth study on the current state of the Diclofenac industry in Global and China. The report provides a basic overview of the industry, including definitions, applications and...

2014-09-10 08:30:23

WOODCLIFF LAKE, N.J. and SAN DIEGO, Sept. 10, 2014 /PRNewswire/ -- Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that data from the Phase 3 clinical trial program for BELVIQ(® )(lorcaserin HCl) CIV will be presented at the American Society of Bariatric Physicians' (ASBP) 64(th) Annual Obesity & Associated Conditions Symposium taking place September 10-13, 2014, in Austin, Texas. "These data presentations continue to support Eisai's efforts to foster a greater...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.